All True Health locations are open and operating under normal business hours.
COVID-19 Testing
Due to the high demand for testing, we have limited testing kits available. At this time, we are no longer scheduling appointments for COVID-19 testing. However, we are accepting walk-ins on a first-come, first-serve basis. Please be advised; it can take up to 14 days to receive test results. Test results can be found in the “Documents” section of your patient portal.
COVID-19 Testing is available on a first-come, first-serve basis at the following sites daily from 8AM-10AM:
Alafaya ♦ Casselberry ♦ Hoffner ♦ Lake Underhill ♦ Sanford
COVID-19 Vaccine
Appointments are now available for the Moderna 2-dose series COVID-19 vaccine, and the Pfizer-BioNTech COVID-19 Vaccine.
Booster Shots and Third Doses:
Booster shots and 3rd doses are also available for both Moderna and Pfizer-BioNTech vaccines for those who are eligible.
On October 21, 2021, the Centers for Disease Control and Prevention (CDC) recommended the use of COVID-19 vaccination boosters for both the Moderna COVID-19 vaccine and Janssen COVID- 19 vaccine (Johnson and Johnson) under the current emergency use authorization. Pfizer-BioNTech COVID-19 vaccine boosters were previously recommended by ACIP on September 24, 2021.
Eligible individuals may choose which vaccine they receive as a booster dose, when available. Some individuals may prefer the vaccine type that they originally received, while others may prefer to get a different booster. The Center for Disease Control and Prevention’s recommendations now allow for this type of mix and match dosing for booster shots of COVID-19 vaccine.
Eligibility:
-
Moderna COVID-19 Vaccine Third Dose:
- Have received your second dose of the Moderna COVID-19 vaccine at least 1 month ago and meet one of the following:
- You are at least 18 years of age and have undergone solid organ transplantation
- Are diagnosed with conditions that are considered to have an equivalent level of immunocompromise
- Have received your second dose of the Moderna COVID-19 vaccine at least 1 month ago and meet one of the following:
-
Moderna COVID-10 Vaccine Booster Dose:
- Have received your second dose of the Moderna COVID-19 vaccine at least 6 months ago and meet one of the following:
- 65 years of age and older
- 18 through 64 years of age at high risk of severe COVID-19
- 18 through 64 years of age with frequent institutional or occupational exposure to SARS- CoV-2
- Have received your second dose of the Moderna COVID-19 vaccine at least 6 months ago and meet one of the following:
-
Pfizer-BioNTech COVID-19 Vaccine Booster Dose
- Have received your second dose of the Pfizer-BioNTech’s COVID-19 vaccine at least 6 months ago and meet one of the following:
- People 65 years and older
- Residents in long-term care settings
- People aged 50–64 years with underlying medical conditions
- People aged 18–49 years with underlying medical conditions
- People aged 18-64 years who are at increased risk for COVID-19 exposure and transmission because of occupational or institutional setting
- Have received your second dose of the Pfizer-BioNTech’s COVID-19 vaccine at least 6 months ago and meet one of the following:
*The Janssen (Johnson & Johnson) COVID-19 vaccine is currently unavailable.
Pediatric COVID-19 Vaccine
True Health is now offering the Pfizer-BioNTech COVID-19 pediatric vaccine for pediatric patients from ages 5-11. Online self-scheduling is available.
Please read the instructions below, then click “Vaccine Scheduling” on your left to schedule your appointment.
Click here to learn more about the Janssen (Johnson & Johnson) single-dose COVID-19 vaccine, the Moderna 2-dose series COVID-19 vaccine, and the Pfizer-BioNTech COVID-19 Vaccine from the CDC.
Monoclonal Antibody Infusion
What is it?
Monoclonal antibody infusion is a new emergency treatment available to those with mild to moderate COVID-19 symptoms, who are at higher risk of worsening conditions. Patients must be within the first 10 days of symptoms. This treatment utilizes the medication Regeneron via IV. Most patients treated with monoclonal antibody infusion report an improvement in symptoms within 24-48 hours. Research shows that receiving this infusion will also lessen the risk of hospitalizations and decrease the risk of mortality.
Most patients note an improvement of symptoms within the first 24-48 hours. They report feeling less fatigued, having a decrease in headaches and body aches, improved appetite, and improvement in shortness of breath.
- Have you had a positive COVID-19 diagnosis within the last 10 days?
- Have you had mild to moderate symptoms of COVID-19 in the last 10-days?
- Fever or chills, cough, shortness of breath or difficulty breathing, fatigue, muscle or body aches, headaches, new loss of taste or smell, sore throat, congestion or runny nose, nausea or vomiting, diarrhea?
- Do you meet one of the criteria listed in the eligibility section?
Click on COVID-19 Infusion Treatment Scheduling on your left and schedule your appointment (no referral or doctor’s order is necessary)
- Patients will remain in our office for approximately 2 ½ hours, which includes 1 hour of monitoring for any potential allergic reactions or side effects.
- The True Health Infusion Center follows strict infection prevention protocols so you can expect a clean environment for the duration of your stay.
- The treatment area is equipped with a television to help pass the time and patient blankets for those who may feel cold during the infusion.
- During your stay, you will receive a discharge bag that includes information on what to expect after the infusion and a pulse oximeter, which you will be trained on how to use and how often to use it. This will help assist in monitoring your oxygen levels at home after the infusion.
- The True Health Infusion staff will also follow up with you 24-hours and 48-hours after your infusion to see how you are feeling and answer any questions you may have.
- The Infusion Center staff will also recommend a 1-week follow-up appointment with your primary care provider. If your primary care provider is from True Health or if you do not have a primary care provider, the Infusion Center staff will create a telehealth visit for you.
There is no out-of-pocket cost for you to receive the monoclonal antibody infusion treatment.
The True Health Infusion Center opened on April 19, 2021 in collaboration with the Seminole County Division of Emergency Management and the Seminole County Health Department. True Health has been treating COVID-19 positive patients since opening, with a majority of patients reporting an improvement in symptoms as soon as 24-hours hours after receiving their infusion. When you choose to receive your Monoclonal Antibody Treatment at True Health, you can expect to receive your infusion in a comfortable environment focused on your health, well-being, and safety.
FDA Emergency Use Authorization (EUA) – https://www.fda.gov/media/143891/download
COVID-19 Testing
Due to the high demand for testing, we have limited testing kits available. At this time, we are no longer scheduling appointments for COVID-19 testing. However, we are accepting walk-ins on a first-come, first-serve basis. Please be advised; it can take up to 14 days to receive test results. Test results can be found in the “Documents” section of your patient portal.
COVID-19 Testing is available on a first-come, first-serve basis at the following sites daily from 8AM-10AM:
Alafaya ♦ Casselberry ♦ Hoffner ♦ Lake Underhill ♦ Sanford
COVID-19 Vaccine
Appointments are now available for the Moderna 2-dose series COVID-19 vaccine and the Pfizer-BioNTech COVID-19 Vaccine.
*The Janssen (Johnson & Johnson) single-dose COVID-19 vaccine is currently unavailable.
Please read the instructions below, then click “Vaccine Scheduling” on your left to schedule your appointment.
Click here to learn more about the Janssen (Johnson & Johnson) single-dose COVID-19 vaccine, the Moderna 2-dose series COVID-19 vaccine, and the Pfizer-BioNTech COVID-19 Vaccine from the CDC.
COVID-19 INFUSION CENTER: FACTS AND BENEFITS
Are you COVID-19 positive? Were you diagnosed in the Last 10 days? Are you > 65 or have any underlying medical conditions?
- If you answered yes to the three questions above, you might benefit from Monoclonal Antibody infusion.
- Monoclonal Antibody infusion is IV medication for patients COVID-19 positive, diagnosed less than 10 days ago, and age 65 or have underlying medical conditions.
- It is available to help reduce symptoms and try to prevent patients from being admitted to the hospital.
Interested?
- Please see your primary care provider and obtain a referral to the True Health IV infusion Center. Please schedule an appointment below.
- If you do not have a primary care provider, please schedule a Telehealth visit to discuss a referral to the True Health IV infusion Center.
COVID-19 is a highly contagious virus, which can affect people of all ages, races and demographics. Symptoms of COVID-19 can be mild to severe. Individuals over the age of 65 and those with co-morbidities are at a higher risk for developing more serious complications leading to hospitalization or even death.
Monoclonal antibody infusion is a new emergency treatment available to those with mild to moderate COVID-19 symptoms who are at higher risk of worsening conditions and are within the first 10 days of diagnosis. There are two medication combinations available for this treatment: Bamlanivimab (BAM)+Etesevimab and Regeneron.
Monoclonal antibodies work the same as the body’s natural defense, only faster. Monoclonal antibodies enter the body and begin to fight off the virus immediately.
Patients diagnosed with COVID-19 and who meet at least one of the following criteria may be eligible to receive the monoclonal antibody infusion.
Eligibility Criteria:
- 65 years of age and older
- 55 years of age and older and have co-morbidities (Cardiovascular Disease, Hypertension, or COPD, etc
- Anyone with BMI over 35, Chronic Kidney Disease, Diabetes, or Immunosuppressive Treatment
- Ages 12-17 weighing a minimum of 40 pounds and have Sickle Cell Disease, Congenital or Acquired Heart Disease, Neurodevelopmental Disorders (Cerebral Palsy), Asthma or dependent on items like tracheostomy or gastrostomy
Bamlanivimab+Etesevimab or Regereron monoclonal antibody infusion is administered via IV solution through the vein, entering the blood stream.
Benefits:
- Treatment with monoclonal antibody IV infusion may help improve COVID-19 symptoms sooner and lessen the risk of patient hospitalizations and decrease the risk of mortality.
- Most patients note an improvement of symptoms within 24 hours; reporting feeling less fatigued, a decrease in headaches and body aches, and improvement in shortness of breath.
- Treatment is outpatient and complete in approximately 2.5 hours, including 1 hour of monitoring for any potential allergic reactions or side effects.
- Patients are sent home after treatment with a pulse oximeter to monitor their own oxygen level and will receive a follow-up call post-infusion to monitor their status.
- True Health is the only health center in Seminole County offering this service, working in collaboration with the Florida Department of Health in Seminole County and Seminole County Emergency Management.
English
Arabic
Chinese (Simplified)
Dutch
French
German
Italian
Portuguese
Russian
Spanish